Guildford, UK, 21 August 2015: ReNeuron Group plc, a leading UK-based stem cell therapy company, announced on 10 July 2015 the details of a Placing in which it had conditionally raised proceeds of £68.4 million before expenses. The Board is pleased to announce that at today’s General Meeting of the Company, shareholders approved all the resolutions by the relevant majorities.

 

Read more…

Back